Clinical Trials Browser

Phase 1 × INDUSTRY × Hypercalcemia × Clear all

NCT00051779 2005-06-24

An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer

Phase 1 Completed

Breast Neoplasms, Hypercalcemia, Neoplasm Metastasis